HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The efficacy of oxamniquine in acute schistosomiasis: a clinical analysis of 28 treated patients.

Abstract
During the summer of 1980, acute Manson's Schistosomiasis occurred in 28 pediatric patients, swimming in two ponds with no watershed connections between them, in the rural area of Juncos and Cidra, Puerto Rico. Clinical and immunological events were studied and Oxamniquine (Vansil, Pfizer) was administered to all of them and followed closely for 3 years. Fever and general malaise recorded in 93% of the patients, diarrhea and abdominal pain in 68% and urticaria or facial edema in 64%. Hepato and/or splenomegaly was recorded in 71% of them. Twenty seven of the patients had evidence of immunoserological activity against adult schistosomal antigens (GASP and PSAP). Two patients had intense immunologic activity, even before the recovering of fresh Schistosoma mansoni eggs in their stool. This was a response to GASP and PSAP antigens. When they started passing fresh eggs of schistosoma and COP (Circumoval Precipitation Test) turned positive, their clinical status worsened and antibodies to GASP antigen increased two fold. The oviposition phase elicited a strong antibody and immunological reaction with significant eosinophilia and cross reaction was observed between adult schistosomal and egg shell antigens. Severe clinical manifestations were seen in spite of low egg excretion. Oxamniquine was effective in obtaining a coprological cure and in altering the immunologic response as compared with other untreated groups in literature.
AuthorsC García Goyco, H Nazario-López, E Ruiz-Tiben, G Vázquez, T Borges, T E Nash
JournalBoletin de la Asociacion Medica de Puerto Rico (Bol Asoc Med P R) 1997 Apr-Jun Vol. 89 Issue 4-6 Pg. 63-9 ISSN: 0004-4849 [Print] Puerto Rico
PMID9432187 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Schistosomicides
  • Oxamniquine
Topics
  • Acute Disease
  • Adolescent
  • Child
  • Disease Outbreaks
  • Humans
  • Oxamniquine (therapeutic use)
  • Puerto Rico (epidemiology)
  • Schistosomiasis (drug therapy, epidemiology)
  • Schistosomicides (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: